Breaking South Korean Stocks Surge Amid AI and Chipmaking Rebound Shohei Ohtani Sidelined by Knee Soreness, Dodgers Opt for Rest Man Convicted in Disappearance of Navajo Elder Arrested on New Charge Family of Deceased Teen Hires Audio Experts to Analyze Distress Call DACA Recipient Files Lawsuit After Deportation, Status Termination Notice

Thursday July 30, 2026

Reporter

Basilea Pharmaceutica International Ltd, Allschwil

1Articles Published

4Communities Covered

Published Articles

Press Release

Basilea receives USD 30 million funding under existing BARDA agreement for advancing phase 3 development of novel antifungal fosmanogepix

Jul 28